| IUPAC name | 6,7,8,9-tetrahydro-5H-tetrazolo[1,5-a]azepine |
| canonical smiles | C1CCC2=NN=NN2CC1 |
| inchi | InChI=1S/C6H10N4/c1-2-4-6-7-8-9-10(6)5-3-1/h1-5H2 |
| inchi key | CWRVKFFCRWGWCS-UHFFFAOYSA-N |
| molecular formula | C6H10N4 |
| synonyms | PentetrazolPentylenetetrazolPENTYLENETETRAZOLE54-95-5Metrazole |
| Compound Description | Pentetrazol appears as white crystalline powder or granular solid with a slightly pungent odor. Bitter taste. Aqueous solutions neutral to litmus. Pentetrazol is an organic heterobicyclic compound that is 1H-tetrazole in which the hydrogens at positions 1 and 5 are replaced by a pentane-1,5-diyl group. A central and respiratory stimulant, it was formerly used for the treatment of cough and other respiratory tract disorders, cardiovascular disorders including hypotension, and pruritis. It is an organic heterobicyclic compound and an organonitrogen heterocyclic compound.Pentetrazol, also known as pentylenetetrazole, is a gamma-aminobutyric acid type A receptor antagonist that was approved by the FDA until 1982.A pharmaceutical agent that displays activity as a central nervous system and respiratory stimulant. It is considered a non-competitive GAMMA-AMINOBUTYRIC ACID antagonist. Pentylenetetrazole has been used experimentally to study seizure phenomenon and to identify pharmaceuticals that may control seizure susceptibility. |
